Clinical Trial: Evaluate Bioequivalence of Burotam (1/1 g/Vial)
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of
Study Type: Interventional
Official Title: A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of Cefoperazone Sodium and Sulbactam Sodium Combination (1/1 g/Vial) After Intravenous Infusion of 1 g
Brief Summary:
A randomized, single-dose, two-way crossover study to evaluate bioequivalence of two formulations of cefoperazone sodium and sulbactam sodium combination (1/1 g/vial) after intravenous infusion of 1 g cefoperazone sodium and 1 g sulbactam sodium in healthy volunteers under fasting conditions
Read more